Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 363,111 | 462,942 | 373,554 | 357,257 | 375,235 |
| Income taxes - deferred | -52,157 | -10,281 | 3,343 | 22,553 | -22,622 |
| Accounts receivable | 252,633 | -382,178 | 98,937 | -58,385 | 183,528 |
| Accounts payable and accrued liabilities | -53,740 | 108,175 | -108,366 | 310,867 | -84,869 |
| Other Working Capital | 297,160 | -358,037 | 152,904 | 88,495 | 281,863 |
| Other Operating Activity | 53,292 | 406,266 | 481,314 | 20,772 | 41,795 |
| Operating Cash Flow | $860,299 | $226,887 | $1,001,686 | $741,559 | $774,930 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -235,354 | -186,990 | -417,959 | -191,916 | -146,504 |
| Net Acquisitions | -2,617 | -3,132 | 35,258 | 140,402 | -8,174 |
| Purchase Of Investment | -74,408 | -70 | -62,077 | -14,041 | 167 |
| Sale Of Investment | 41,617 | 20,713 | 26,548 | 11,550 | 12,457 |
| Investing Cash Flow | $-270,762 | $-169,479 | $-418,230 | $-54,005 | $-142,054 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 342,578 | 103,569 | -53,111 | 65,096 | -87,841 |
| Debt Issued | 104,798 | 46,232 | 500,760 | 7,590 | 1,100,107 |
| Debt Repayment | -594,405 | -166,105 | -161,943 | -676,974 | -465,093 |
| Common Stock Repurchased | -144,642 | -347,331 | -434,166 | N/A | N/A |
| Other Financing Activity | -477,864 | -72,451 | -59,929 | -530,965 | -467,950 |
| Financing Cash Flow | $-769,535 | $-436,086 | $-208,389 | $-1,135,253 | $79,223 |
| Exchange Rate Effect | 2,104 | 18,710 | -32,176 | -16,216 | -70,651 |
| Beginning Cash Position | 1,239,145 | 1,599,113 | 1,256,222 | 1,720,137 | 1,078,689 |
| End Cash Position | 1,061,251 | 1,239,145 | 1,599,113 | 1,256,222 | 1,720,137 |
| Net Cash Flow | $-179,998 | $-378,678 | $375,067 | $-447,699 | $712,099 |
| Free Cash Flow | |||||
| Operating Cash Flow | 860,299 | 226,887 | 1,001,686 | 741,559 | 774,930 |
| Capital Expenditure | -240,396 | -190,066 | -423,012 | -192,214 | -154,383 |
| Free Cash Flow | 619,903 | 36,821 | 578,674 | 549,345 | 620,547 |